Skip to content

A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty

A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02104934
Enrollment
40
Registered
2014-04-07
Start date
2014-03-31
Completion date
2016-03-31
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia in Total Knee Arthroplasty

Brief summary

Total knee arthroplasty or replacement (TKA), a commonly performed surgery for osteoarthritis of the knee, is a painful procedure and requires a multimodal analgesic approach. A method for analgesia is local infiltration analgesia (LIA), where a mixture of drugs is injected around the knee joint. Adductor canal block (ACB) is an alternative regional anaesthesia technique which has been shown to result in minimal thigh weakness. The investigators aim to study if the analgesia provided by ACB is superior to LIA while preserving quadriceps strength.

Interventions

PROCEDUREAdductor Canal Block

Sponsors

Changi General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for primary TKA under single shot spinal anaesthesia, between ages 45-85 years old, American Society of Anesthesiologists (ASA) physical status 1 to 3 and BMI 18-35 kg/m2

Exclusion criteria

* Patients unable to give consent, inability to communicate/ cooperate, patients with regular consumption of strong opioids (morphine, oxycodone) or steroids, allergy to local anaesthetics or any drugs included in the study, patients with lower limb surgery in the preceding year, patients with pre-existing neurological deficits and patients who have contraindications for spinal anaesthesia.

Design outcomes

Primary

MeasureTime frameDescription
Morphine consumption in the first 24 hours24 hoursmorphine consumption in the first 24 hours (including morphine administered in recovery and via PCA).

Secondary

MeasureTime frameDescription
Pain Scores1, 6, 12, 24 hours; up to 48 hours postoperativePain scores are recorded at 1, 6, 12, 24 and 48 hours post-operatively, assessed using a visual analog scale (0-100mm) at rest and during 45 degree passive flexion of knee.
Morphine ConsumptionAt 48 hoursThe balance usage after primary outcome
Postoperative Nausea and VomitingUp to 48 hoursPresence/absence of nausea and vomiting, and total number of episodes of vomiting
Sedation ScoresUp to 48 hours
Quadriceps Strengthat 24 and 48 hours

Other

MeasureTime frameDescription
Presence of Complicationsup to 48 hoursHematoma, wound infection, neurological deficits, any incidence of fall
Length of Hospital StayUp to 30 daysNumber of days till discharge

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026